This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stringer, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stringer, J. R.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 10 1996, 489-498, Vol 9, No. 4
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Pneumocystis carinii: what is it, exactly?

JR Stringer
Department of Molecular Genetics, Biochemistry and Microbiology, College of Medicine, University of Cincinnati, OH 45267-0524, USA. stringjr@ucbeh.san.uc.edu

The identity of Pneumocystis carinii has been uncertain for many years. Until recently, it was widely regarded to be a protozoan because it does not grow in culture and is not susceptible to antifungal drugs. Although these and a number of other phenotypic characteristics of P. carinii differ from those of typical fungi, analysis of DNA sequences has shown that P. carinii is a member of the fungal lineage of eukaryotes. However, a close phylogenetic relative of P. carinii has not yet been found. Analysis of gene sequences has also revealed that P. carinii is not a single entity but that the genus Pneumocystis contains a complex group of organisms. P. carinii organisms from one host species do not grow when introduced into another host species, and P. carinii isolates from different host species are more genetically divergent from one another than might be expected for members of the same species. Genetic variation of a lesser degree also occurs among P. carinii organisms from the same host species, suggesting that it may be possible to identify strains and to conduct transmission and epidemiological studies. Results of early studies exploiting genetic variation among P. carinii isolates from patients have suggested that recurrent P. carinii pneumonia may not always be caused by reactivation of latent organisms, as is commonly believed. However, other features of P. carinii suggest that this microbe has established a long-term relationship with its host. A striking new development in this regard is the discovery of a genetic system that is designed to allow variation in the structure of a major antigen on the surface of P. carinii.


This article has been cited by other articles:

  • Meissner, N. N., Lund, F. E., Han, S., Harmsen, A. (2005). CD8 T Cell-Mediated Lung Damage in Response to the Extracellular Pathogen Pneumocystis Is Dependent on MHC Class I Expression by Radiation-Resistant Lung Cells. J. Immunol. 175: 8271-8279 [Abstract] [Full Text]  
  • Meissner, N. N., Swain, S., Tighe, M., Harmsen, A., Harmsen, A. (2005). Role of Type I IFNs in Pulmonary Complications of Pneumocystis murina Infection. J. Immunol. 174: 5462-5471 [Abstract] [Full Text]  
  • Lutzoni, F., Kauff, F., Cox, C. J., McLaughlin, D., Celio, G., Dentinger, B., Padamsee, M., Hibbett, D., James, T. Y., Baloch, E., Grube, M., Reeb, V., Hofstetter, V., Schoch, C., Arnold, A. E., Miadlikowska, J., Spatafora, J., Johnson, D., Hambleton, S., Crockett, M., Shoemaker, R., Sung, G.-H., Lucking, R., Lumbsch, T., O'Donnell, K., Binder, M., Diederich, P., Ertz, D., Gueidan, C., Hansen, K., Harris, R. C., Hosaka, K., Lim, Y.-W., Matheny, B., Nishida, H., Pfister, D., Rogers, J., Rossman, A., Schmitt, I., Sipman, H., Stone, J., Sugiyama, J., Yahr, R., Vilgalys, R. (2004). Assembling the fungal tree of life: progress, classification, and evolution of subcellular traits. Am. J. Bot. 91: 1446-1480 [Abstract] [Full Text]  
  • Keely, S. P., Fischer, J. M., Cushion, M. T., Stringer, J. R. (2004). Phylogenetic identification of Pneumocystis murina sp. nov., a new species in laboratory mice. Microbiology 150: 1153-1165 [Abstract] [Full Text]  
  • Cushion, M. T., Keely, S. P., Stringer, J. R. (2004). Molecular and phenotypic description of Pneumocystis wakefieldiae sp. nov., a new species in rats. Mycologia 96: 429-438 [Abstract] [Full Text]  
  • Swain, S. D., Lee, S. J., Nussenzweig, M. C., Harmsen, A. G. (2003). Absence of the Macrophage Mannose Receptor in Mice Does Not Increase Susceptibility to Pneumocystis carinii Infection In Vivo. Infect. Immun. 71: 6213-6221 [Abstract] [Full Text]  
  • Xu, Z., Lance, B., Vargas, C., Arpinar, B., Bhandarkar, S., Kraemer, E., Kochut, K. J., Miller, J. A., Wagner, J. R., Weise, M. J., Wunderlich, J. K., Stringer, J., Smulian, G., Cushion, M. T., Arnold, J. (2003). Mapping by Sequencing the Pneumocystis Genome Using the Ordering DNA Sequences V3 Tool. Genetics 163: 1299-1313 [Abstract] [Full Text]  
  • Keely, S. P., Cushion, M. T., Stringer, J. R. (2003). Diversity at the Locus Associated with Transcription of a Variable Surface Antigen of Pneumocystis carinii as an Index of Population Structure and Dynamics in Infected Rats. Infect. Immun. 71: 47-60 [Abstract] [Full Text]  
  • Van Dross, R. T., Sanders, M. M. (2002). Molecular Characterization of Recombinant Pneumocystis carinii Topoisomerase I: Differential Interactions with Human Topoisomerase I Poisons and Pentamidine. Antimicrob. Agents Chemother. 46: 2145-2154 [Abstract] [Full Text]  
  • Baggish, A. L., Hill, D. R. (2002). Antiparasitic Agent Atovaquone. Antimicrob. Agents Chemother. 46: 1163-1173 [Full Text]  
  • Nahimana, A., Cushion, M. T., Blanc, D. S., Hauser, P. M. (2001). Rapid PCR-Single-Strand Conformation Polymorphism Method To Differentiate and Estimate Relative Abundance of Pneumocystis carinii Special Forms Infecting Rats. J. Clin. Microbiol. 39: 4563-4565 [Abstract] [Full Text]  
  • Kovacs, J. A., Gill, V. J., Meshnick, S., Masur, H. (2001). New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia. JAMA 286: 2450-2460 [Abstract] [Full Text]  
  • Miller, R. F., Ambrose, H. E., Wakefield, A. E. (2001). Pneumocystis carinii f. sp. hominis DNA in Immunocompetent Health Care Workers in Contact with Patients with P. carinii Pneumonia. J. Clin. Microbiol. 39: 3877-3882 [Abstract] [Full Text]  
  • Demanche, C., Berthelemy, M., Petit, T., Polack, B., Wakefield, A. E., Dei-Cas, E., Guillot, J. (2001). Phylogeny of Pneumocystis carinii from 18 Primate Species Confirms Host Specificity and Suggests Coevolution. J. Clin. Microbiol. 39: 2126-2133 [Abstract] [Full Text]  
  • van der Lee, T., Robold, A., Testa, A., van `t Klooster, J. W., Govers, F. (2001). Mapping of Avirulence Genes in Phytophthora infestans With Amplified Fragment Length Polymorphism Markers Selected by Bulked Segregant Analysis. Genetics 157: 949-956 [Abstract] [Full Text]  
  • Smulian, A. G., Sesterhenn, T., Tanaka, R., Cushion, M. T. (2001). The ste3 Pheromone Receptor Gene of Pneumocystis carinii Is Surrounded by a Cluster of Signal Transduction Genes. Genetics 157: 991-1002 [Abstract] [Full Text]  
  • Stringer, J. R., Keely, S. P. (2001). Genetics of Surface Antigen Expression in Pneumocystis carinii. Infect. Immun. 69: 627-639 [Abstract] [Full Text]  
  • Cushion, M. T., Orr, S., Keely, S. P., Stringer, J. R. (2001). Time between Inoculations and Karyotype Forms of Pneumocystis carinii f. sp. carinii Influence Outcome of Experimental Coinfections in Rats. Infect. Immun. 69: 97-107 [Abstract] [Full Text]  
  • Palmer, R. J., Settnes, O. P., Lodal, J., Wakefield, A. E. (2000). Population Structure of Rat-Derived Pneumocystis carinii in Danish Wild Rats. Appl. Environ. Microbiol. 66: 4954-4961 [Abstract] [Full Text]  
  • NAHIMANA, A., BLANC, D. S., FRANCIOLI, P., BILLE, J., HAUSER, P. M. (2000). Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections. J Med Microbiol 49: 753-758 [Abstract] [Full Text]  
  • Kaneshiro, E. S., Collins, M. S., Cushion, M. T. (2000). Inhibitors of Sterol Biosynthesis and Amphotericin B Reduce the Viability of Pneumocystis carinii f. sp. carinii. Antimicrob. Agents Chemother. 44: 1630-1638 [Abstract] [Full Text]  
  • Aviles, P., Aliouat, E.-M., Martinez, A., Dei-Cas, E., Herreros, E., Dujardin, L., Gargallo-Viola, D. (2000). In Vitro Pharmacodynamic Parameters of Sordarin Derivatives in Comparison with Those of Marketed Compounds against Pneumocystis carinii Isolated from Rats. Antimicrob. Agents Chemother. 44: 1284-1290 [Abstract] [Full Text]  
  • Kaneshiro, E. S., Amit, Z., Swonger, M. M., Kreishman, G. P., Brooks, E. E., Kreishman, M., Jayasimhulu, K., Parish, E. J., Sun, H., Kizito, S. A., Beach, D. H. (1999). Pneumocysterol [(24Z)-ethylidenelanost-8-en-3beta -ol], a rare sterol detected in the opportunistic pathogen Pneumocystis carinii hominis: Structural identity and chemical synthesis. Proc. Natl. Acad. Sci. USA 96: 97-102 [Abstract] [Full Text]  
  • Fishman, J. A. (1998). Prevention of Infection Due to Pneumocystis carinii. Antimicrob. Agents Chemother. 42: 995-1004 [Full Text]  
  • Kaneshiro, E. S. (1998). The Lipids of Pneumocystis carinii. Clin. Microbiol. Rev. 11: 27-41 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»